@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@stpiindia 3 years ago
#BigData & #AI can accelerate developing precision medicines and new therapies by assisting researchers rev up drug discovery process. Explore how #STPINEURON is helping #startups to build such soln: https://www.neuron.stpi.in/. #STPICoEs #STPIINDIA #STPIINCUBATION #GrowWithSTPI https://t.co/RJiRPwUACl
@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com 6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks